StockData
Armata Pharmaceuticals, Inc. logo

Armata Pharmaceuticals, Inc. (ARMP) stock

ARMPNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/30
$2.66−0.33 (-11.04%)

Close on Nov 17, 2026Market cap $98.90MP/E –Yield –

Earnings

Armata Pharmaceuticals's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 24, 2027
Q4 FY2026 · estimated, during market hours
Revenue, Q3 FY2026
$3.20M
+166.7% on a year earlier
EPS, Q3 FY2026
-$0.24
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Armata Pharmaceuticals's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Mar 24, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 12, 2026after the close$3.20M+166.7%-$0.24Release
Q2 FY2026ended Jun 30, 2026Aug 12, 2026during market hours$2.50M–-$0.27Release
Q1 FY2026ended Mar 31, 2026May 13, 2026during market hours$800.00K+60.0%-$3.16Release
Q4 FY2025ended Dec 31, 2025Mar 25, 2026during market hours$1.10M-8.3%-$3.42Release
Q3 FY2025ended Sep 30, 2025Nov 12, 2025during market hours$1.20M-60.0%–Release
Q2 FY2025ended Jun 30, 2025Aug 12, 2025during market hours–––Release
Q1 FY2025ended Mar 31, 2025May 14, 2025during market hours$500.00K-50.0%–Release
Q4 FY2024ended Dec 31, 2024Mar 21, 2025after the close$1.20M-20.0%-$0.23Release
Q3 FY2024ended Sep 30, 2024Nov 13, 2024during market hours$3.00M+150.0%-$0.15Release
Q2 FY2024ended Jun 30, 2024Aug 13, 2024during market hours–––Release
Q1 FY2024ended Mar 31, 2024May 7, 2024during market hours$1.00M+25.0%–Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Armata Pharmaceuticals has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Armata Pharmaceuticals puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Armata Pharmaceuticals filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. News
  3. Update
  4. Results
  5. Update
  6. Update
  7. News
  8. Results
  9. Update
  10. Update
  11. Results
  12. Update
  13. Update
  14. Update
  15. Results

See a number that looks wrong?